Lifecore Biomedical (FRA:LDE) E10: €-0.92 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LDE Lifecore Biomedical Inc FRA:LDE
58 GF Score
Price €3.98
GF Value €5.64
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Lifecore Biomedical E10?

Lifecore Biomedical FRA:LDE -2.45% 58 E10 is €-0.92 as of Mar. 2026. GuruFocus rates FRA:LDE with a GF Score™ of 58/100 and a GF Value™ of €5.64 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lifecore Biomedical's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.372. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.92 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -57.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lifecore Biomedical was 52.90% per year. The lowest was -57.70% per year. And the median was -2.20% per year.

As of today (2026-07-15), Lifecore Biomedical's current stock price is €3.98. Lifecore Biomedical's E10 for the quarter that ended in Mar. 2026 was €-0.92. Lifecore Biomedical's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Lifecore Biomedical was 106.00. The lowest was 22.85. And the median was 32.89.


Lifecore Biomedical  (FRA:LDE) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Lifecore Biomedical was 106.00. The lowest was 22.85. And the median was 32.89.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lifecore Biomedical E10 Related Terms


Lifecore Biomedical E10 Historical Data

* Premium members only.

The historical data trend for Lifecore Biomedical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifecore Biomedical E10 Chart

Lifecore Biomedical Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 -0.25 -0.63 -0.72 -0.90

Lifecore Biomedical Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.91 -0.90 -0.87 0.00 -0.92

FRA:LDE vs ANIK, DERM, ASRT: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Shiller PE Ratio falls into.


FRA:LDE
58GF Score
Lifecore Biomedical Inc FRA:LDE
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lifecore Biomedical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lifecore Biomedical's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.372/330.2130*330.2130
=-0.372

Current CPI (Mar. 2026) = 330.2130.

Lifecore Biomedical Quarterly Data

per share eps CPI Adj_EPS
201605 0.150 240.229 0.206
201608 0.107 240.849 0.147
201611 0.046 241.353 0.063
201702 0.122 243.603 0.165
201705 0.081 244.733 0.109
201708 0.068 245.519 0.091
201711 0.017 246.669 0.023
201802 0.462 248.991 0.613
201805 0.186 251.588 0.244
201808 0.009 252.146 0.012
201811 -0.018 252.038 -0.024
201902 0.026 252.776 0.034
201905 -0.009 256.092 -0.012
201908 -0.144 256.558 -0.185
201911 -0.208 257.208 -0.267
202002 -0.358 258.678 -0.457
202005 -0.477 256.394 -0.614
202008 -0.321 259.918 -0.408
202011 -0.381 260.229 -0.483
202102 -0.157 263.014 -0.197
202105 -0.082 269.195 -0.101
202108 -0.272 273.567 -0.328
202111 -1.139 277.948 -1.353
202202 -0.396 283.716 -0.461
202205 -1.173 292.296 -1.325
202208 -0.365 296.171 -0.407
202211 -0.422 297.711 -0.468
202302 -1.121 300.840 -1.230
202305 -1.095 304.127 -1.189
202308 -0.321 307.026 -0.345
202311 0.360 307.051 0.387
202402 0.389 310.326 0.414
202405 -0.222 314.069 -0.233
202408 -0.481 314.796 -0.505
202411 -0.235 315.493 -0.246
202502 -0.451 319.082 -0.467
202505 -0.053 321.465 -0.054
202509 -0.247 324.800 -0.251
202512 0.000 324.054 0.000
202603 -0.372 330.213 -0.372

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.92 mean?
Lifecore Biomedical (FRA:LDE) has a E10 of €-0.92 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lifecore Biomedical and its competitors.
Is Lifecore Biomedical's E10 too high?
Lifecore Biomedical's current E10 is €-0.92. Overall, Lifecore Biomedical has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lifecore Biomedical's E10 compare to ANIK and DERM?
Lifecore Biomedical's E10 of €-0.92 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lifecore Biomedical and its competitors. Lifecore Biomedical's current E10 is €-0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecore Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Lifecore Biomedical (FRA:LDE) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.64, compared to a current price of €3.98 — trading 29.4% below its estimated fair value. The current E10 is €-0.92. Lifecore Biomedical's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Lifecore Biomedical (FRA:LDE), the current E10 is €-0.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lifecore Biomedical (FRA:LDE) Overvalued in 2026?

Based on GuruFocus' analysis, Lifecore Biomedical stock appears to be undervalued. The current stock price of €3.98 is trading 29.4% below its estimated GF Value™ of €5.64. GuruFocus considers Lifecore Biomedical to be Modestly Undervalued.

Key valuation signals for FRA:LDE:

  • E10: €-0.92
  • GF Value™: €5.64 vs. price of €3.98 (29.4% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the FRA:LDE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lifecore Biomedical Business Description

Other Exchanges LFCR:USA
Address 3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
58GF Score

Get the complete analysis for FRA:LDE

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.98
Price
€5.64
GF Value